<?xml version="1.0" encoding="UTF-8"?>
<p id="Par46">Recent failures in large Phase III clinical trials for PD suggest that disease modification will not succeed as long as PD is treated as a single disease with one pathophysiology. Therefore, we believe that precision medicine in PD may be a promising alternative and a timely approach.</p>
